Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant polyclonal antibody libraries.

J Sharon1, S Sarantopoulos, W Den

  • 1Department of Pathology and Laboratory Medicine, Boston University School of Medicine, MA 02118, USA. jsharon@bu.edu

Combinatorial Chemistry & High Throughput Screening
|July 21, 2000
PubMed
Summary

This study introduces a novel technology for creating recombinant polyclonal antibody libraries (PCALs). This method generates standardized antibody mixtures for multi-antigen targeting, combining benefits of polyclonal and monoclonal approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's Knowledge of Bladder Health: What We Have Learned in the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium.

Current bladder dysfunction reports·2023
Same author

Biomarkers in chronic graft-versus-host disease: quo vadis?

Bone marrow transplantation·2018
Same author

B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.

Bone marrow transplantation·2017
Same author

Interventions to improve patient understanding of cancer clinical trial participation: a systematic review.

European journal of cancer care·2016
Same author

Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD.

Bone marrow transplantation·2015
Same author

The complex interplay among bacterial motility and virulence factors in different Escherichia coli infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Traditional antibody therapies often face limitations like antigen escape variants and inconsistent supply.
  • Monoclonal antibodies offer standardization but may lack the avidity and effector functions of polyclonal antibodies.

Purpose of the Study:

  • To present a new technology for generating recombinant polyclonal antibody libraries (PCALs).
  • To combine the advantages of polyclonal antibodies (multi-antigen targeting, high avidity) with those of monoclonal antibodies (standardization, unlimited supply).

Main Methods:

  • Creation of phage display Fab antibody libraries.
  • Selection of sublibraries specific for desired antigens.
  • Mass transfer of variable region gene pairs to mammalian expression vectors for whole antibody generation.

Related Experiment Videos

Main Results:

  • Successful selection of phage display antibody libraries against microbial and tumor cell targets.
  • Demonstration of a method to generate standardized polyclonal whole antibody libraries.
  • Potential for creating reagents with high avidity and reduced antigen escape.

Conclusions:

  • The described technology enables the creation and perpetuation of standardized polyclonal whole antibody mixtures.
  • This approach offers a powerful platform for developing advanced antibody therapeutics and research tools.
  • The method integrates phage display selection with mammalian expression for versatile antibody library generation.